Finnish startup Enifer sets sights on U.S. protein market: 'This is really significant for us'
10 sep. 2025
12:44
Finnish mycoprotein maker Enifer is ready to enter the U.S. food market after clearing a key regulatory hurdle.
CEO Simo Ellilä tells Impact Loop about the company's plans to conquer a huge but already crowded market, and why European regulations are pushing biotech startups toward the U.S.
CEO Simo Ellilä tells Impact Loop about the company's plans to conquer a huge but already crowded market, and why European regulations are pushing biotech startups toward the U.S.
Finnish biotech scaleup Enifer has cleared a crucial hurdle on its path to commercializing its flagship mycoprotein ingredient in the United States as it seeks to carve out a share of the fast-expanding market for alternative proteins.
The company announced Tuesday it has achieved self-affirmed GRAS (Generally Recognized as Safe) status, enabling it to begin selling its fungi-based mycoprotein to U.S. food manufacturers.